Tyler Laszewski
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Peptidase Inhibition and Analysis
- Immunology top 10%
- Immune cells in cancer
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Cytokine Signaling Pathways and Interactions 1
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Sandra S. McAllister (4 shared papers)Molly J. DeCristo (3 shared papers)John N. Hutchinson (2 shared papers)Jessalyn M. Ubellacker (2 shared papers)Andrew H. Beck (1 shared paper)Alex Toker (1 shared paper)Francisco Beça (1 shared paper)Tiffany Tsang (1 shared paper)
- Journals
- Nature Cell Biology (1 paper)PLoS Biology (1 paper)Cancer Immunology Research (1 paper)PLoS ONE (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Tyler Laszewski
6 papers receiving 557 citations
Peers
Comparison fields: 5 of 71
- Oncology 313
- Immunology 228
- Cancer Research 120
- Molecular Biology 236
- Physiology 11
Countries citing papers authored by Tyler Laszewski
This map shows the geographic impact of Tyler Laszewski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tyler Laszewski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tyler Laszewski more than expected).
Fields of papers citing papers by Tyler Laszewski
This network shows the impact of papers produced by Tyler Laszewski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tyler Laszewski. The network helps show where Tyler Laszewski may publish in the future.
Co-authors
The 25 scholars most cited alongside Tyler Laszewski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 147 | |
| 2 | 2018 | 130 | |
| 3 | 2019 | 110 | |
| 4 | 2016 | 103 | |
| 5 | 2022 | 63 | |
| 6 | 2018 | 7 |
About Tyler Laszewski
Tyler Laszewski is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 6 papers that have together received 560 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Metabolism, Diabetes, and Cancer (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Nanoplatforms for cancer theranostics (1 paper), Inflammatory Bowel Disease (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Oncology (313 citations), Immunology (228 citations), Cancer Research (120 citations), Molecular Biology (236 citations) and Physiology (11 citations). Tyler Laszewski has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Sandra S. McAllister, Molly J. DeCristo, John N. Hutchinson, Jessalyn M. Ubellacker, Andrew H. Beck, Alex Toker, Francisco Beça, Tiffany Tsang, Whitney S. Henry and Glenn Dranoff. Their work appears in journals such as Nature Cell Biology, PLoS Biology, Cancer Immunology Research, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.